For example, in a mid-stage human study, people taking higher doses (up to 12mg) lost an average of 24% of their body weight over 48 weeks, which is about 58 pounds for some
"Semaglutide has the potential to change how we manage metabolic disorders
Low Blood Sugar Semaglutide is a glucagon-like peptide-1 receptor agonist, and although its insulinotropic effect is glucose-dependent, it can still lower glucose in people without diabetes, particularly when combined with other glucose-lowering therapies or prolonged fasting
Conclusion: Both subcutaneous and oral semaglutide administration could enable the achievement of sufficient glycemic control and weight management without increasing the risk of hypoglycemia, which were effective and safe for the treatment of T2D
& Courcoulas, A
Youre engaging with someone who empathizes deeply, who has experienced similar struggles and triumphed